跳至主要内容
临床试验/ACTRN12613000334707
ACTRN12613000334707尚未招募2 期

A randomized controlled trial of fish-oil supplementation for children with autism spectrum disorder.

Princess Margaret Hospital0 个研究点目标入组 50 人开始时间: 2013年3月26日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
2 Years 至 6 Years(—)
性别
All

入选标准

  • Children with a DSM-IV diagnosis of ASD (including Autistic Disorder, Pervasive-Developmental Disorder Not Otherwise Specified (PDD-NOS) and Asperger’s Syndrome)

排除标准

  • 1. A fish allergy
  • 2. Are taking medication for other medical conditions (including diabetes, blood pressure)
  • 3. Are currently taking psychotropic medication for the treatment of aggression, tantrums or self-injurious behaviour
  • 4. Have diabetes
  • 5. Have a bleeding disorder
  • 6. Have a seizure disorder
  • 7. Have other serious medical conditions
  • 8. Current or prior ( < 3 months prior to the intervention) use of omega-3 fatty acids.

研究者

相似试验

A randomized controlled trial of fish-oil... | 临床试验